This symposium will cover progress in the design and synthesis of protease inhibitors for a diverse range of disease indications, while also covering a range of novel drug discovery activities: from 'Molecules to Medicines'. This meeting is aimed at medicinal chemists and other scientists interested in furthering their knowledge of proteases in the context of drug discovery.
Deadlines
Useful links
Downloads
-
Proteinase - first-announce-web.pdf
-
Understanding the role of proteolysis in disease, Charles Craik
-
Development of novel activity-based probes for the detection of serine proteases, Timothy Ferguson
-
Second announcement
-
Discovery of orally available, potent and selective plasma kallikrein inhibitors, Michael Evans
-
Potent non-covalent inhibitors of caspase-1, Ajay Chandgude, University of Groningen
